Literature DB >> 21860840

Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers?

Abeer Zeitoun1, Maya Zeineddine, Hani Dimassi.   

Abstract

AIM: To evaluate the current practice of stress ulcer prophylaxis (SUP) in Lebanese Health care centers.
METHODS: A multi-center prospective chart review study was conducted over 8 mo. A questionnaire was distributed to pharmacy students who collected data on demographics, SUP medications, dose, route, duration and associated risk factors. The appropriateness of SUP use was determined as per American Society of Health-System Pharmacists guidelines. Institutional review board approval was obtained from each hospital center.
RESULTS: A total of 1004 patients were included. 67% of the patients who received prophylaxis did not have an indication for SUP. The majority (71.6%) of the patients who were administered parenteral drugs can tolerate oral medications. Overall, the regimen of acid-suppressant drugs was suboptimal in 87.6% of the sample. This misuse was mainly observed in non-teaching hospitals.
CONCLUSION: This study highlighted the need, in Lebanese hospitals, to establish clinical practice guidelines for the use of SUP; mainly in non-critical care settings.

Entities:  

Keywords:  American Society of Health-System Pharmacists guidelines; Histamine 2 receptor antagonists; Lebanese hospitals; Proton-pump inhibitors; Stress ulcer prophylaxis

Year:  2011        PMID: 21860840      PMCID: PMC3158880          DOI: 10.4292/wjgpt.v2.i4.27

Source DB:  PubMed          Journal:  World J Gastrointest Pharmacol Ther        ISSN: 2150-5349


  62 in total

Review 1.  GI complications in patients receiving mechanical ventilation.

Authors:  G M Mutlu; E A Mutlu; P Factor
Journal:  Chest       Date:  2001-04       Impact factor: 9.410

Review 2.  Acute gastrointestinal bleeding in the intensive care unit. The gastroenterologist's perspective.

Authors:  U Beejay; M M Wolfe
Journal:  Gastroenterol Clin North Am       Date:  2000-06       Impact factor: 3.806

3.  Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate.

Authors:  M Tryba
Journal:  Crit Care Med       Date:  1991-07       Impact factor: 7.598

4.  Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials.

Authors:  A Messori; S Trippoli; M Vaiani; M Gorini; A Corrado
Journal:  BMJ       Date:  2000-11-04

5.  Change in prescribing patterns of intravenous histamine2-receptor antagonists results in significant cost savings without adversely affecting patient care.

Authors:  K A Fudge; K A Moore; D N Schneider; T P Sherrin; G S Wellman
Journal:  Ann Pharmacother       Date:  1993-02       Impact factor: 3.154

Review 6.  Stress ulcer prophylaxis in hospitalized patients not in intensive care units.

Authors:  Rebekah R Arthur Grube; D Byron May
Journal:  Am J Health Syst Pharm       Date:  2007-07-01       Impact factor: 2.637

7.  Endoscopic and histopathological evaluation of acute gastric injury in high-dose acetaminophen and nonsteroidal anti-inflammatory drug ingestion with suicidal intent.

Authors:  Aliye Soylu; Can Dolapcioglu; Kemal Dolay; Aydin Ciltas; Nurgul Yasar; Mustafa Kalayci; Halil Alis; Nurten Sever
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

8.  Prophylaxis of gastrointestinal tract bleeding in patients admitted to a general hospital ward. Comparative study of sucralfate and cimetidine.

Authors:  J M Grau; J Casademont; J Fernández-Solá; F Cardellach; A Urbano-Márquez
Journal:  Scand J Gastroenterol       Date:  1993-03       Impact factor: 2.423

Review 9.  Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysis.

Authors:  T Ben-Menachem; B D McCarthy; R Fogel; R M Schiffman; R V Patel; B J Zarowitz; D R Nerenz; R S Bresalier
Journal:  Crit Care Med       Date:  1996-02       Impact factor: 7.598

10.  Inappropriate continuation of stress ulcer prophylactic therapy after discharge.

Authors:  Paul D Wohlt; Lizbeth A Hansen; Jeffrey T Fish
Journal:  Ann Pharmacother       Date:  2007-09-11       Impact factor: 3.154

View more
  9 in total

1.  Impact of a multidisciplinary quality improvement initiative to reduce inappropriate usage of stress ulcer prophylaxis in hospitalized patients.

Authors:  Yeo Jin Choi; Joohyun Sim; Yun Tae Jung; Sooyoung Shin
Journal:  Br J Clin Pharmacol       Date:  2020-01-22       Impact factor: 4.335

2.  Assessment of pharmacologic prophylaxis use against stress ulcer in the medical wards of University of Gondar Hospital.

Authors:  Boressa Adugna Horsa; Yohanes Ayele; Mohammed Biset Ayalew
Journal:  SAGE Open Med       Date:  2019-02-02

3.  Attachment to stress ulcer prophylaxis guideline in the neurology wards of two teaching and non-teaching hospitals: A retrospective survey in Iran.

Authors:  Farzaneh Foroughinia; Mohammad Madhooshi
Journal:  J Res Pharm Pract       Date:  2016 Apr-Jun

4.  Critical Appraisal of the Quality of Clinical Practice Guidelines for Stress Ulcer Prophylaxis.

Authors:  Zhi-Kang Ye; Ying Liu; Xiang-Li Cui; Li-Hong Liu
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

5.  Impact of clinical pharmacist interventions on inappropriate prophylactic acid suppressant use in hepatobiliary surgical patients undergoing elective operations.

Authors:  Hongli Luo; Qingze Fan; Shunlin Xiao; Kun Chen
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

6.  Assessment of counseling practice in medicine retail outlets in Mekelle City, Northern Ethiopia.

Authors:  Yared Belete Belay; Terefe Teshome Kassa; Abraham Gebregziabiher Welie; Merafe Samuel Alemayehu; Fantaye Teka Dinkashe
Journal:  Risk Manag Healthc Policy       Date:  2017-08-07

7.  Variables Associated with Adherence to Stress Ulcer Prophylaxis in Patients Admitted to the General Hospital Wards: A Prospective Study.

Authors:  Shadi Farsaei; Sajad Ghorbani; Payman Adibi
Journal:  Adv Pharm Bull       Date:  2017-04-13

8.  Appropriateness of Acid-suppressing Agents for Stress Ulcer Prophylaxis in Non-intensive Care Unit Setting in Saudi Arabia.

Authors:  Ala Malhis; Taghreed Alghamdi; Reem Alfandi; Zahra AlHaj Issa; Hadeel Alanazi; Hend Alfintoukh; Jaffer Bin Baqar; Sheraz Ali
Journal:  J Pharm Bioallied Sci       Date:  2019 Jan-Mar

9.  Potentially inappropriate medications prescribing to elderly patients with advanced chronic kidney by using 2019 American Geriatrics Society Beers Criteria.

Authors:  Bahia Chahine
Journal:  Health Sci Rep       Date:  2020-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.